Jemma Arakelyan: Just completed the ESMO Advanced Course on lung cancer
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post on LinkedIn:
“Just completed the ESMO – European Society for Medical Oncology Advanced Course on lung cancer – what an incredible learning experience! I am immensely grateful to ESMO and the organizers for providing the opportunity to learn firsthand from field experts.
Key takeaways:
- Advanced diagnostics and personalized treatments are transforming lung cancer care.
- Targeted therapies and immunotherapy show great promise.
- Precision medicine based on genomic profiling is shaping the future of treatment.
- Multidisciplinary approaches are improving patient outcomes.
Exciting times in lung cancer research!”
Source: Jemma Arakelyan/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023